Dermatofibroma medical therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
Dermatofibromas are [[benign]] and no treatment is generally needed. | Dermatofibromas are [[benign]] and no treatment is generally needed. | ||
If the treatment is needed, [[local]] [[excision]] is the mainstay one.<ref name="JakobiecTu2017">{{cite journal|last1=Jakobiec|first1=Frederick A.|last2=Tu|first2=Yufei|last3=Zakka|first3=Fouad R.|last4=Tong|first4=Arthur K.F.|title=Dermatofibroma of the eyelid with monster cells|journal=Survey of Ophthalmology|volume=62|issue=4|year=2017|pages=533–540|issn=00396257|doi=10.1016/j.survophthal.2016.12.007}}</ref> | * If the treatment is needed, [[local]] [[excision]] is the mainstay one.<ref name="JakobiecTu2017">{{cite journal|last1=Jakobiec|first1=Frederick A.|last2=Tu|first2=Yufei|last3=Zakka|first3=Fouad R.|last4=Tong|first4=Arthur K.F.|title=Dermatofibroma of the eyelid with monster cells|journal=Survey of Ophthalmology|volume=62|issue=4|year=2017|pages=533–540|issn=00396257|doi=10.1016/j.survophthal.2016.12.007}}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 14:36, 29 August 2019
|
Dermatofibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dermatofibroma medical therapy On the Web |
|
American Roentgen Ray Society Images of Dermatofibroma medical therapy |
|
Risk calculators and risk factors for Dermatofibroma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
There is no pharmacologic medical therapy for dermatofibromas . Dermatofibromas are benign and no treatment is generally needed. If the treatment is needed, local excision is the mainstay one.
Medical Therapy
Dermatofibromas are benign and no treatment is generally needed.
References
- ↑ Jakobiec, Frederick A.; Tu, Yufei; Zakka, Fouad R.; Tong, Arthur K.F. (2017). "Dermatofibroma of the eyelid with monster cells". Survey of Ophthalmology. 62 (4): 533–540. doi:10.1016/j.survophthal.2016.12.007. ISSN 0039-6257.